Concord Medical Services (NYSE:CCM) vs Oncology Institute (NASDAQ:TOI) Critical Review


Concord Medical Services (NYSE:CCM – Get Rating) and Oncology Institute (NASDAQ:TOI – Get Rating) are both small-cap medical companies, but which is the better stock? We’ll compare the two companies based on earnings strength, risk, profitability, valuation, analyst recommendations, dividends, and institutional ownership.

Valuation and benefits

This table compares revenue, earnings per share (EPS), and valuation of Concord Medical Services and Oncology Institute.

Gross revenue Price/sales ratio Net revenue Earnings per share Price/earnings ratio
Concorde Medical Services $34.18 million 2.24 -$47.51 million N / A N / A
Institute of Oncology $203.00 million 2.57 -$10.93 million N / A N / A

Oncology Institute has higher revenue and profit than Concord Medical Services.

Profitability

This table compares the net margins, return on equity and return on assets of Concord Medical Services and Oncology Institute.

Net margins Return on equity return on assets
Concorde Medical Services N / A N / A N / A
Institute of Oncology N / A 78.66% 7.84%

Risk and Volatility

Concord Medical Services has a beta of -0.13, which means its stock price is 113% less volatile than the S&P 500. In comparison, Oncology Institute has a beta of 1.65, which means its stock price is 65% more volatile than the S&P 500.

Analyst Notes

This is a summary of current recommendations for Concord Medical Services and Oncology Institute, as reported by MarketBeat.

Sales Ratings Hold odds Buy reviews Strong buy odds Rating
Concorde Medical Services 0 0 0 0 N / A
Institute of Oncology 0 0 0 0 N / A

Insider and Institutional Ownership

0.4% of Concord Medical Services shares are held by institutional investors. 46.5% of Concord Medical Services shares are held by insiders. Strong institutional ownership indicates that endowments, hedge funds, and large fund managers believe a stock will outperform the market over the long term.

Summary

Oncology Institute beats Concord Medical Services on 6 out of 8 factors compared between the two stocks.

Concord Medical Services Company Profile (Get an evaluation)

Concord Medical Services Holding Ltd. operates radiotherapy and diagnostic imaging centers. It provides radiotherapy and diagnostic equipment rental services to hospitals; and the sale of medical equipment and the provision of radiation therapy and diagnostic equipment rental and management services to hospitals, It operates through the Network Business and Hospital Business segments. The company was founded on November 27, 2007 and is based in Beijing, China.

Oncology Institute Corporate Profile (Get an evaluation)

The Institute of Oncology is involved in the delivery of value-based oncology care. The Institute of Oncology, formerly known as DFP Healthcare Acquisitions Corp., is based in NEW YORK.



Get news and reviews for Concord Medical Services Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Concord Medical Services and related companies with MarketBeat.com’s free daily email newsletter.